Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (sln) after duodenal administration to rats. Part II—Tissue distribution-Reference-Cited by-同舟云学术

Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (sln) after duodenal administration to rats. Part II—Tissue distribution

Published:2001-05 Issue:5 Volume:43 Page:497-502
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Bargoni Alessandro,Cavalli Roberta,Zara Gian Paolo,Fundarò Anna,Caputo Otto,Gasco Maria Rosa

Publisher

Elsevier BV

Subject

Pharmacology

Reference38 articles.

1. The use of antibiotics;Kucers,1987

2. Frequency of nephrotoxicity with vancomycin and aminoglucosyde antibiotic therapy;Hailemeskel;Hosp Pharm,1999

3. Possible tobramycin delirium;McCartney;JAMA,1982

4. An alternative colloidal carrier system for controlled drug delivery;Müller;Eur J Pharm Biopharm,1995

5. Solid lipid nanoparticles (SLN) for controlled drug delivery. I production, characterization and sterilization;Schwartz;Int J Pharm,1992

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Nanoparticle-Based Strategies for Enhanced Antibacterial Interventions;Cell Biochemistry and Biophysics;2024-07-18

2. Confocal reflectance microscopy for metal and lipid nanoparticle visualization in the brain;Nanomedicine;2022-03

3. Synthesis and Potential Applications of Lipid Nanoparticles in Medicine;Materials;2022-01-17

4. Brain Infectious Diseases and Nanotherapy;Nanotechnology for Infectious Diseases;2022

5. Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB;Pharmaceutics;2021-07-31